# China NMPA Inspection - Changchun Institute of Biochemical Pharmaceuticals and Medical Devices - July 25, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/changchun-institute-of-biochemical-pharmaceuticals-and-medical-devices/3ba36dff-86c7-4344-96b0-269d87428f70/
Source feed: China

> China NMPA unannounced inspection for Changchun Institute of Biochemical Pharmaceuticals and Medical Devices published July 25, 2019. On July 25-26, 2019, the Jilin Provincial Drug Administration, operating under the National Medical Products Administration (NMPA) framework, announce

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Jilin Provincial Drug Administration's Announcement on the Cancellation of Cosmetic Production License (No. 1 of 2019)
- Company Name: Changchun Institute of Biochemical Pharmaceuticals and Medical Devices
- Publication Date: 2019-07-25
- Product Type: cosmetics
- Summary: On July 25-26, 2019, the Jilin Provincial Drug Administration, operating under the National Medical Products Administration (NMPA) framework, announced the cancellation of Cosmetics Production Licenses for three companies. This action was taken in accordance with the 'Cosmetics Production Licensing Work Specifications.' Two of the companies, Changchun Kexin Biochemical Pharmaceutical and Medical Device Research Institute (License No. Jilin Cosmetics 20170005) and Tonghua Shengjixin Biotechnology Co., Ltd. (License No. Jizhuang 20160009), voluntarily applied for the cancellation of their licenses. Both were licensed for general liquid and cream/emulsion unit production, including skin care water, cleansing, and other skin care items. The third company, Changchun Xingtai Biotechnology Co., Ltd. (License No. Jizhuang 20160004), faced license cancellation because its existing Cosmetics Production License had expired and was not renewed. This company was authorized for general liquid, cream/lotion, and powder unit production. The regulatory action resulted in the immediate cancellation of their respective production licenses. This announcement serves as a public record of the administrative decisions made by the Jilin Provincial Drug Administration regarding compliance and licensing within the cosmetics manufacturing sector.

Company: https://www.globalkeysolutions.net/companies/changchun-institute-of-biochemical-pharmaceuticals-and-medical-devices/104e513a-abb2-4006-9fa5-58b832b686e2/